The Impact of the Coronavirus Disease 19 Pandemic on Early Pregnancy Outcomes Among Patients Undergoing In Vitro Fertilization Treatment
Author:
Affiliation:
1. Department of Obstetrics, Gynecology, and Reproductive Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
2. Reproductive Medicine Associates of New York, New York, New York, USA.
Publisher
Mary Ann Liebert Inc
Link
https://www.liebertpub.com/doi/pdf/10.1089/whr.2021.0054
Reference33 articles.
1. 1. ASRM COVID-19 Task Force. Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic. Washington, DC: American Society for Reproductive Medicine, 2020.
2. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS‐CoV‐2 infection among hospitalized pregnant women: A systematic review
3. Is termination of early pregnancy indicated in women with COVID-19?
4. A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective
5. Clinical features and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assisted Reproductive Technology During COVID-19: A Population-Based Study Of Pregnancy Outcomes;Reproductive Sciences;2024-07-19
2. Impacts of the COVID-19 pandemic on early pregnancy outcomes among women undergoing frozen-thawed embryo transfer: a retrospective cohort study;Human Fertility;2023-09-05
3. Embryo development, pregnancy and live birth outcomes following IVF treatment were not compromised during the COVID-19 pandemic;Journal of Assisted Reproduction and Genetics;2023-07-10
4. Antifosfolipidnye antitela i iskhody programm vspomogatel'nyh reproduktivnyh tekhnologij u pacientok s SOVID-19 v anamneze;Вестник Российского государственного медицинского университета;2022-10
5. Antiphospholipid antibodies and outcomes of assisted reproductive technology programs in patients with a history of COVID-19;Bulletin of Russian State Medical University;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3